A critical discovery in cancer study is emerging with the use of nanobodies to re-engage dysfunctional p53. This essential malignant inhibitor protein is frequently inactivated in various forms of malignancies, leading https://reallivesocial.com/story7654616/vhh-fragments-restore-the-p53-protein-a-potential-hope-for-tumor-management